$0.3251
-0.0022-0.67%
Dern. MÀJ: Nov 18, 12:16 PM

Tempest Therapeutics (TPST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Nov 13, 2026 | $-0.21 | $-0.32 | 34.4 % |
| Q2 | Aug 13, 2026 | $-0.34 | $-0.30 | -13.3 % |
| Q1 | May 14, 2026 | $-0.50 | $-0.28 | -80.0 % |
| Q4 | Mar 30, 2026 | $-0.62 | $-0.62 | 0.00 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.32 | $-0.30 | $-0.28 | $-0.62 |
| Actual | $-0.21 | $-0.34 | $-0.50 | $-0.62 |
| Surprise | +34.4% | -13.3% | -80.0% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.18 |
| Revenue | |
| Consensus | — |